cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2024)

cbdMD has disclosed Asset Writedowns and Impairment across 8 years of filings, most recently posting $921314.0 for Q3 2024.

• Asset Writedowns and Impairment for Q3 2024 came in at $921314.0, up 229.87% year-over-year; the trailing twelve-month figure through Sep 2024 was $921314.0 (up 424.97% YoY), and the FY2025 annual result was $365979.0, down 60.28% from the prior year.
• Asset Writedowns and Impairment came in at $921314.0 for Q3 2024 at cbdMD, up from -$709393.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $30.8 million in Q2 2022 to a low of -$49.0 million in Q3 2022.
• The 5-year median for Asset Writedowns and Impairment is $684284.5 (2020), against an average of -$2.0 million.
• Across the five-year window, Asset Writedowns and Impairment slumped 7401.1% in 2022 and surged 229.87% in 2024, its largest moves.
• cbdMD's Asset Writedowns and Impairment stood at -$526628.0 in 2020, then surged by 227.33% to $670580.0 in 2021, then soared by 31.96% to $884892.0 in 2022, then plunged by 180.17% to -$709393.0 in 2023, then soared by 229.87% to $921314.0 in 2024.
• The last three Asset Writedowns and Impairment figures came in at $921314.0 (Q3 2024), -$709393.0 (Q3 2023), and $884892.0 (Q4 2022), per Business Quant data.